Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Viatris Inc.

Viatris Inc. (VTRS) Stock Overview

Explore Viatris Inc.’s financial performance, market position, analyst ratings, and future outlook.

VTRS●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$18.12
$0.15(0.82%)
U.S. Market opens in 13h 22m

Viatris Inc. (VTRS)

Meyka AI Score

Z

Key Financials

Market Cap21.1B
P/E Ratio-50.33
EPS (TTM)$2.52
ROE-0.03%
Fundamental Analysis

AI Price Forecasts

1 Month$16.96
3 Months$19.09
1 Year Target$20.25

VTRS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Viatris Inc. (NASDAQ: VTRS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Viatris Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of VTRS on the NASDAQ shows an RSI of 69.35, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $20.25 for the NASDAQ listing.

Key metrics behind Viatris Inc.'s NASDAQ-traded stock include a P/E ratio of -50.33 and a market capitalization of 21.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of VTRS on the NASDAQ.

Price Performance (NASDAQ: VTRS)

1-Day Change
-0.82%
5-Day Change
6.28%
1-Month Change
10.89%
3-Month Change
11.65%
6-Month Change
38.85%
Year-to-Date (YTD) Change
45.54%
1-Year Change
88.36%
3-Year Change
83.77%
5-Year Change
30.74%
All-Time (Max) Change
36140.00%

Contact Information

https://www.viatris.com
724 514 1800
Robert J. Coury Global Center, Canonsburg, PA, 15317

Company Facts

300,000 Employees
IPO DateMar 17, 1980
CountryUS
Actively Trading

Frequently Asked Questions